The Nocebo Effect

被引:17
|
作者
Colloca, Luana [1 ,2 ]
机构
[1] Univ Maryland, Dept Pain & Translat Symptom Sci, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Nursing, Placebo Opin Ctr, Baltimore, MD 21201 USA
基金
美国国家卫生研究院;
关键词
negative outcomes; expectancy; discontinuation; framing effects; nonadherence; learning; side effects; MU-OPIOID RECEPTOR; PLACEBO GROUPS; NONCONSCIOUS ACTIVATION; SOCIAL OBSERVATION; HEALTH COMPLAINTS; CLINICAL-TRIALS; ADVERSE EVENTS; WIND TURBINES; CHRONIC PAIN; SPINAL-CORD;
D O I
10.1146/annurev-pharmtox-022723-112425
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Adverse nocebo responses can cause harm to patients and interfere with treatment adherence and effects in both clinic practice and clinical trials. Nocebo responses refer to negative outcomes to active medical treatments in clinical trials or practice that cannot be explained by the treatment's pharmacologic effects. Negative expectancies and nocebo effects are less known than placebo responses. Nocebo effects can be triggered by verbal suggestions, prior negative experiences, observation of others experiencing negative outcomes, and other contextual and environmental factors. As research advances over the years, mechanistic knowledge is accumulating on the neurobiological mechanisms of nocebo effects. This review summarizes studies on different facets of nocebo effects and responses and discusses clinical implications, ethical considerations, and future directions.
引用
收藏
页码:171 / 190
页数:20
相关论文
共 50 条
  • [21] Nocebo is the enemy, not placebo. A meta-analysis for the nocebo effect in headaches
    Mitsikostas, D. D.
    Chalarakis, N. G.
    Mantonakis, L., I
    CEPHALALGIA, 2009, 29 : 39 - 39
  • [22] The Nocebo Effect in Rheumatology: An Unexplored Issue
    Cantini, Fabrizio
    Niccoli, Laura
    Franchi, Giulia
    Damiani, Arianna
    Benucci, Maurizio
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2020, 22 (03): : 185 - 190
  • [23] Sensitivity to electromagnetic fields: the nocebo effect
    Nicolle-Mir, Laurence
    ENVIRONNEMENT RISQUES & SANTE, 2011, 10 (02): : 93 - 94
  • [24] Editorial: nocebo effect and switching to biosimilars
    van Bodegraven, A. A.
    Boone, N. W.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (06) : 850 - 851
  • [26] Commentary: Harm, Truth, and the Nocebo Effect
    Ho, Dien
    CAMBRIDGE QUARTERLY OF HEALTHCARE ETHICS, 2020, 29 (02) : 236 - 245
  • [27] The nocebo effect in the context of statin intolerance
    Tobert, Jonathan A.
    Newman, Connie B.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2016, 10 (04) : 739 - 747
  • [28] Pseudogenerics Substitution is Not Associated to a Nocebo Effect
    Leclerc, Jacinthe
    Blais, Claudia
    Rochette, Louis
    Hamel, Denis
    Guenette, Line
    Beaudoin, Claudia
    Poirier, Paul
    CIRCULATION, 2018, 138
  • [29] The Nocebo Effect: Overdiagnosis and Its Costs
    Haller, John S., Jr.
    MEDICAL HISTORY, 2017, 61 (01) : 146 - 147
  • [30] Communication in the ICU: An Unintended Nocebo Effect
    Guiance, I. Riestra
    Shilling, D.
    Varga, K.
    Niven, A. S.
    Wallace, L.
    Philbrick, K.
    Chitulangoma, J.
    Gajic, O.
    Weiman, M.
    Schmitt, E.
    Pasko, D.
    Karnatovskaia, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205